Free Trial

Polyrizon (PLRZ) Competitors

Polyrizon logo
$0.0035 0.00 (-16.67%)
As of 12:16 PM Eastern

PLRZ vs. UPC, NCNA, HSTO, SMFL, ADTX, SCPS, EVLO, GNCAQ, GNCA, and ARDS

Should you be buying Polyrizon stock or one of its competitors? The main competitors of Polyrizon include Universe Pharmaceuticals (UPC), NuCana (NCNA), Histogen (HSTO), Smart for Life (SMFL), Aditxt (ADTX), Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), and Aridis Pharmaceuticals (ARDS). These companies are all part of the "pharmaceutical products" industry.

Polyrizon vs.

Polyrizon (NASDAQ:PLRZ) and Universe Pharmaceuticals (NYSE:UPC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, community ranking, earnings and profitability.

Polyrizon and Universe Pharmaceuticals both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
PolyrizonN/AN/A
Universe PharmaceuticalsN/AN/A

0.2% of Universe Pharmaceuticals shares are held by institutional investors. 57.4% of Universe Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Polyrizon had 2 more articles in the media than Universe Pharmaceuticals. MarketBeat recorded 2 mentions for Polyrizon and 0 mentions for Universe Pharmaceuticals. Polyrizon's average media sentiment score of 0.84 beat Universe Pharmaceuticals' score of 0.00 indicating that Polyrizon is being referred to more favorably in the media.

Company Overall Sentiment
Polyrizon Positive
Universe Pharmaceuticals Neutral

Polyrizon has higher earnings, but lower revenue than Universe Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PolyrizonN/AN/AN/AN/AN/A
Universe Pharmaceuticals$23.02M0.01-$6.16MN/AN/A

Company Net Margins Return on Equity Return on Assets
PolyrizonN/A N/A N/A
Universe Pharmaceuticals N/A N/A N/A

Summary

Universe Pharmaceuticals beats Polyrizon on 3 of the 5 factors compared between the two stocks.

Get Polyrizon News Delivered to You Automatically

Sign up to receive the latest news and ratings for PLRZ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PLRZ vs. The Competition

MetricPolyrizonPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$15,000.00$6.47B$5.31B$8.31B
Dividend YieldN/A2.64%5.20%4.10%
P/E RatioN/A8.5926.6919.58
Price / SalesN/A257.78393.58120.51
Price / CashN/A65.8538.2534.62
Price / BookN/A6.396.744.47
Net IncomeN/A$143.98M$3.23B$248.32M
7 Day PerformanceN/A-0.06%0.01%-1.26%
1 Month PerformanceN/A1.64%8.69%10.52%
1 Year PerformanceN/A-0.73%18.36%8.53%

Polyrizon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PLRZ
Polyrizon
N/A$0.00
-16.7%
N/AN/A$15,000.00N/A0.00N/AGap Down
High Trading Volume
UPC
Universe Pharmaceuticals
N/A$4.91
-4.1%
N/A-99.6%$211,000.00$23.02M0.00220
NCNA
NuCana
2.1992 of 5 stars
$0.03
+5.2%
$25.00
+72,154.3%
-98.9%$197,000.00N/A0.0030Gap Down
High Trading Volume
HSTO
Histogen
N/A$0.03
-4.6%
N/A-82.4%$133,000.00$19,000.00-0.0120Gap Down
SMFL
Smart for Life
N/A$0.02
+483.3%
N/A-99.7%$124,000.00$11.11M0.00110Gap Down
High Trading Volume
ADTX
Aditxt
0.8548 of 5 stars
$1.66
+1.8%
N/A-100.0%$95,000.00$133,985.000.0060
SCPS
Scopus BioPharma
N/A$0.00
flat
N/AN/A$13,000.00N/A0.009
EVLO
Evelo Biosciences
N/A$0.00
flat
N/AN/A$6,000.00N/A0.00120
GNCAQ
Genocea Biosciences
N/AN/AN/AN/A$6,000.00N/A0.0070
GNCA
Genocea Biosciences
N/AN/AN/AN/A$6,000.00$1.91M0.0070News Coverage
Analyst Forecast
ARDS
Aridis Pharmaceuticals
N/A$0.00
flat
N/A-99.7%$5,000.00$3.09M0.0030

Related Companies and Tools


This page (NASDAQ:PLRZ) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners